Liaoning 49 drug shortage 2 drug companies are fined for breaking supply

Source: saibelan on November 20, 2017 reported that 49 drugs were in short supply, and 2 pharmaceutical companies were fined for breaking supply! Recently, the health and Family Planning Commission of Liaoning Province issued the notice on Issuing the No 3 drug shortage early warning forecast of Liaoning Province in 2017 (hereinafter referred to as the notice) According to the notice, from July to September 2017, there were 49 drugs in short supply in Liaoning Province Up to now, there are still 5 drugs in short supply The shortage of 40 kinds of drugs is mainly caused by the temporary shortage of raw materials or the untimely distribution In addition, two drug companies were punished because of drug supply interruption! According to the research and decision of the leading group office for centralized procurement of drugs and medical consumables of medical institutions in Liaoning Province, in view of the fact that Guangdong Xinbao Pharmaceutical Technology Co., Ltd does not make rectification after warning, Guangdong Xinbao Pharmaceutical Technology Co., Ltd will be disqualified from participating in the centralized procurement of drugs in Liaoning Province, and will be included in the bad credit record of pharmaceutical purchase and sale in Liaoning Province Henan Runhong Pharmaceutical Co., Ltd was given a warning and rectification within a time limit Xinbao pill, a medicine that cannot be supplied at the bid price, is used to treat chronic cardiac insufficiency caused by deficiency of heart and kidney yang, obstruction of heart vessels and blood stasis: bradycardia caused by insufficiency of sinoatrial node, sick sinus syndrome, angina pectoris caused by ischemic heart disease and ischemic change of electrocardiogram Xinbao pill is a Medicare medicine for industrial injury At present, it is produced by three pharmaceutical enterprises, including Tongrentang, a time-honored pharmaceutical enterprise Atropine sulfate injection is mainly used to rescue septic shock and organophosphorus pesticide poisoning At present, the variety has 208 approval numbers, including famous pharmaceutical enterprises such as Shiyao group Some insiders said that although atropine sulfate has a large number of documents, its application scope is small, the market is relatively narrow, the price is low, and the profit space is small Many enterprises have given up production, and the shortage is not a one-day success Although it is not uncommon for pharmaceutical enterprises to punish them for not supplying according to the bid price, the pharmaceutical enterprises that do not supply according to the bid price are still going on and on It seems that the so-called "bid price" has become an unbearable weight for many pharmaceutical enterprises In addition to the three drugs that cannot be supplied according to the bid winning price, there are five drugs that are short of drugs due to shortage of raw materials, price rise or change of production plant Drugs in short supply